CDEK by Data4ThePeople
Sign in Sign up
← All organizations

OncoImmune, Inc.

For profitWebsite ↗

Also known as: OncoImmune, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2014

Last known activity

Oct 30, 2020

Acquired by Merck on Nov 23, 2020

Timeline

2000s

  1. Jun 1, 2000

    OncoImmune, Inc.— Founded

2020s

  1. Nov 23, 2020

    Merck— Acquired By

Drugs by trial phase (9 distinct, 8 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

Details

Founded
Rockville, MD, US Jun 1, 2000
Last known activity
Oct 30, 2020